Early detection of Hepatitis C in people who inject drugs
Early Detection of Hepatitis C in Injection Drug Users
This study is testing new ways to find Hepatitis C early in people who inject drugs to help prevent it from spreading and improve their care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Institute of Health Information and Statistics of the Czech Republic Government |
| Locations | 18 sites (Brno and 17 other locations) |
| Trial ID | NCT06431945 on ClinicalTrials.gov |
What this trial studies
This project is a national, multicenter pilot initiative aimed at screening for Hepatitis C Virus (HCV) among people who inject drugs (PWID) in the Czech Republic. It involves approximately 3,000 participants across 18 clinical centers, focusing on the early detection of HCV to prevent further transmission. The study will evaluate new methods for screening and establish a continuous care methodology for early diagnosis and treatment. The project is supported by the European Social Fund and aims to improve the social health care system.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 18 and older who are currently injecting drugs or have a history of injecting drug use.
Not a fit: Patients who do not inject drugs or have never used injecting drugs will not benefit from this study.
Why it matters
Potential benefit: If successful, this project could significantly reduce the transmission of Hepatitis C among injecting drug users.
How similar studies have performed: Other studies focusing on early detection and screening of Hepatitis C in similar populations have shown promising results, indicating that this approach is both relevant and potentially effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * age 18+ * an active injecting drug user or have used injecting drugs at any time in the past Exclusion Criteria: * not agreeing to participate in the project
Where this trial is running
Brno and 17 other locations
- Brno University Hospital — Brno, Czechia (Recruiting)
- Clinic Podane ruce — Brno, Czechia (Recruiting)
- České Budějovice Hospital — České Budějovice, Czechia (Recruiting)
- Hospital Havířov — Havířov, Czechia (Recruiting)
- Hepatogastroenterology Hradec Kralove — Hradec Králové, Czechia (Recruiting)
- University Hospital Hradec Kralove — Hradec Králové, Czechia (Recruiting)
- Hospital Jihlava — Jihlava, Czechia (Recruiting)
- Regional Hospital Karlovy Vary — Karlovy Vary, Czechia (Recruiting)
- University Hospital Olomouc — Olomouc, Czechia (Recruiting)
- Hospital Opava — Opava, Czechia (Recruiting)
- Hospital Pardubice — Pardubice, Czechia (Recruiting)
- Institute for Clinical and Experimental Medicine — Prague, Czechia (Recruiting)
- Military University Hospital, Prague — Prague, Czechia (Recruiting)
- Remedis Prague — Prague, Czechia (Recruiting)
- Hospital Agel Prostějov — Prostějov, Czechia (Recruiting)
- Hospital Tábor — Tábor, Czechia (Recruiting)
- Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s. — Ústí nad Labem, Czechia (Recruiting)
- Tomáš Baťa Regional Hospital in Zlín — Zlín, Czechia (Recruiting)
Study contacts
- Study coordinator: Nikola Stourac
- Email: nikola.stourac@uzis.cz
- Phone: +42073901254
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.